← FDA Drug Approvals (Drugs@FDA)
VENLAFAXINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMADAX · Approved 2022-01-04
Drug application
- FDA Application #
ANDA214423- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- VENLAFAXINE HYDROCHLORIDE
- Generic name
- Venlafaxine Hydrochloride
- Active ingredients
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PHARMADAX
- First approval
- 2022-01-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown